Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium Study (Q33392287)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium Study |
scientific article |
Statements
1 reference
Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium Study (English)
1 reference
Riccardo Riccardi
1 reference
Isabelle Aerts
1 reference
Birgit Geoerger
1 reference
Didier Frappaz
1 reference
Christian Michel Zwaan
1 reference
Julia Chisholm
1 reference
Marie-Cecile Le Deley
1 reference
Jean-Claude Gentet
1 reference
Nathalie Dias
1 reference
Timothy Jaspan
1 reference
Kieran Mc Hugh
1 reference
Dominique Couanet
1 reference
Sharon Hain
1 reference
Annick Devos
1 reference
Colosimo Cesare
1 reference
Joachim Boos
1 reference
Gilles Vassal
1 reference
European Consortium Innovative Therapies for Children with Cancer (ITCC)
1 reference
11 October 2010
1 reference
1 reference
47
1 reference
230-238
1 reference
Identifiers
1 reference
1 reference